During the past decade, Castle Hill Hospital; The Queens Centre for Oncology and Haematology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" #1 collaborator was "Itreas" with 2 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" are "Breast Cancer" (3 trials), "Deep Venous Thrombosis" (2 trials), "Pulmonary Embolism" (2 trials), "Venous Thromboembolism" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" in a lesser frequency.

Most popular intervention types in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Abelacimab" (2 trials), "Carboplatin" (2 trials), "5-FU/LV" (1 trials) and "AG-221" (1 trials). Other intervention names were less common.

The vast majority of trials in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Castle Hill Hospital; The Queens Centre for Oncology and Haematology". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Castle Hill Hospital; The Queens Centre for Oncology and Haematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Castle Hill Hospital; The Queens Centre for Oncology and Haematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".